P3 round two funding up for grabs
25 August, 2004 by Renate KrelleResearch and development funding is up for grabs once more under round two of the federal government’s $150 million Pharmaceuticals Partnerships Program – known as P3 – which opened for applications today.
Amrad on track, with global ambitions
23 August, 2004 by Melissa TrudingerAmrad's (ASX: AML) annual results were in line with company expectations for the financial year and were an indication of the progress made in building and restructuring the management team for future growth, chairman Bob Moses said today.
Chemeq CEO to step down
23 August, 2004 by Melissa TrudingerAs Chemeq (ASX: CMQ) continues its efforts to raise capital through a placement to institutional and sophisticated investors, CEO and chairman Graham Melrose has announced plans to step down from the CEO role, remaining non-executive chairman.
NZ bio calls for $650m biotech bridge; SA govt approves incubator
19 August, 2004 by Graeme O'NeillNew Zealand’s biotechnology industry wants the NZ government to establish a NZ$650-660 million, taxpayer-funded bridge between the nation’s research laboratories and its biotech business sector.
Somnomed placement closes early and oversubscribed
18 August, 2004 by Melissa TrudingerSleep apnoea and snoring device company Somnomed has closed its oversubscribed placement a week early, ahead of an expected float on August 27, 2004.
Nugent wins Victoria Prize
18 August, 2004 by Melissa TrudingerThe Victoria Prize was awarded today to Melbourne University physicist Prof Keith Nugent for his work on phase imaging and X-ray optics.
Expressions of interest sought for trade mission to UK
17 August, 2004 by Melissa TrudingerExpressions of interest are being sought from Australian biotechnology companies interested in joining a trade mission to the United Kingdom and BioPartnering Europe 2004.
TasInformatics ready for take-off
16 August, 2004 by Melissa TrudingerThe AUD$20 million flagship project of Tasmania's Intelligent Island initiative funded by the Australian Government and jointly managed with the state government -- the Tasinformatics Centre of Excellence at the University of Tasmania -- is due to get off the ground in the coming weeks, once final negotiations between the university and the state government have been completed.
Chemeq calls trading halt, appeals for more capital
16 August, 2004 by Melissa TrudingerChemeq (ASX: CMQ) has called a trading halt while it considers a proposal to raise equity funds to use as working capital and to expand its current production facility from 20 tonnes annual production capacity to 50 tonnes.
Origin Capital's $6.5 million biotech play
16 August, 2004 by Melissa TrudingerOrigin Capital, an unlisted pooled development fund set up by TSL Group's Ross Dobinson and Michael Naphtali, has raised AUD$6.5 million in private equity for investment into three biotech ventures.
Early-stage funding is out there for those who deserve it
16 August, 2004 by Melissa TrudingerThe early stage funding is out there, but would-be biotech companies need to demonstrate quality to get the cash, according to the people who hold the seed-funding purse strings.
NZ to kick in $5 million for Synchrotron
13 August, 2004 by Melissa TrudingerNew Zealand will provide AUD$5 million towards the synchrotron beamlines, pushing beamline funding over $25 million - half of the $49 million required to set up the initial suite of beamlines.
Epitan raises $8 million in private placement
11 August, 2004 by Renate KrelleEpiTan (ASX: EPT) has raised AUD$7.98 million via a private placement of 10.5 million fully paid ordinary with two European investors.
'Just add water' works for BTF
09 August, 2004 by Renate KrelleThere must be something in the water in Sydney’s North Ryde that encourages biotech.
CSIRO’s IP revenues on the up
05 August, 2004 by Graeme O'NeillCSIRO has reported sharp rise in intellectual property revenues 2003-04 financial year, to $22 million -- a 60 per cent increase on its 2003-03 figure of $13.75 million.
